headaches and tirzepatide Unanticipated Adverse Events With Tirzepatide: Three Cases Underscoring the Importance of Postmarketing Monitoring Does Mounjaro Cause Headaches? |

For the treatment of obesity, GLP-1RAs and GIP/ GLP-1RAs are indicated in patients with a body mass index (BMI) 30 kg m 2 , or 27 kg m 2 in the presence of at least one weight-related comorbidity, to support weight reduction [23]

1), S124S138

[1] [4] As with many subcutaneous injections, skin reactions at the injection site are among the most frequently reported adverse effects

Clinical trial results showed participants taking oral Wegovy achieved an average weight loss of approximately 17%, highlighting its potential to expand treatment options for people living with obesity or overweight with weight-related conditions